Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 25, 2026
KLA Corporation (KLAC) Falls -18.7% Over 30 Days: Key Drivers and What Comes Next

KLA Corporation (KLAC) Falls -18.7% Over 30 Days: Key Drivers and What Comes Next

Key Takeaways

  • KLA Corporation (KLAC) shares declined approximately 18.7% over the past 30 days, falling from $258.80 on June 25 to $210.52 on July 24.
  • The stock hit an all-time high of $301.71 on June 30 before a sharp reversal triggered by insider selling, valuation concerns, and broad semiconductor sector rotation.
  • Despite the 30-day pullback, KLAC remains up roughly 10.8% over the last quarter, supported by robust AI-driven demand for process control and advanced packaging equipment.
  • Upcoming Q4 FY2026 earnings on July 28 are a critical near-term catalyst, with consensus estimates at $1.00 EPS and $3.61 billion in revenue.
  • Wall Street analysts maintain a Moderate Buy consensus with an average price target of approximately $280, implying significant potential upside from current levels.

KLA Corporation (KLAC) Company Overview and Market Position

KLA Corporation is the global leader in semiconductor process control and yield management solutions. The company designs and manufactures inspection, metrology, and data analytics systems that enable chipmakers to detect defects, measure critical dimensions, and maximize manufacturing yields throughout the wafer fabrication process. KLAC commands a dominant 58% market share in process control — roughly 7.5 times larger than its nearest competitor — and serves virtually every major semiconductor manufacturer worldwide. With a growing presence in advanced packaging inspection, a services business generating highly recurring revenue, and deep exposure to secular trends in artificial intelligence and high-performance computing, KLA is widely regarded as one of the most structurally advantaged companies in the semiconductor capital equipment sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

KLA Corporation (KLAC) Stock Price Performance: Last 30 Days vs. Quarter

KLAC shares closed at $210.52 on July 24, 2026, representing a decline of approximately 18.7% from the June 25 close of $258.80. The stock experienced enormous volatility during this period. After rallying to an all-time intraday high of $307.37 on June 30 — driven by Intel's raised capital expenditure guidance, analyst price target increases, and momentum across the semiconductor equipment space — KLAC abruptly reversed course. By July 7, the stock had fallen to $216.47, and selling pressure persisted through mid-July, with shares touching an intraday low of $204.58 on July 17 before stabilizing near $210–$218 in the final trading sessions.

Over the broader quarter, the picture is notably different. From approximately $190.00 in late April, KLAC gained roughly 10.8%, underscoring the fact that the recent sell-off predominantly reflects a correction from overbought, overvalued levels rather than fundamental deterioration in the company's business outlook.

What Drove KLAC Stock Price in the Last 30 Days

The 30-day decline was driven by multiple converging factors. First, insider selling acted as a key catalyst. On July 1, CFO Bren D. Higgins sold 27,701 shares at an average price of $265.69, while EVP Mary Beth Wilkinson sold 14,392 shares at $285.30 on July 2. Although Wilkinson's sale was disclosed as tax-related, the timing near the stock's peak triggered a negative sentiment shift. KLAC gapped down sharply on July 7, opening at $217.12 after closing the prior session at $233.31.

Second, valuation concerns intensified. After gaining roughly 80% year-to-date and trading at over 50 times forward earnings and approximately 17 times sales, institutional investors began questioning whether the risk-reward profile remained favorable. Vltava Fund, a prominent value-oriented investment firm, disclosed that it exited its entire position in KLAC — alongside positions in LRCX and AMAT — during the second quarter, citing an imbalance between price and quality at 20 times sales and 50 times earnings.

Third, broader semiconductor sector weakness contributed meaningfully. The Philadelphia Semiconductor Index (SOX) dropped approximately 18% from its late-June all-time high, as elevated expectations and stretched valuations across the semicon equipment space prompted widespread profit-taking ahead of the July earnings season. From what I see, this sector-wide rotation played a major role in the timing of the pullback.

What Drove KLAC Stock Performance Over the Last Quarter

Over the last quarter, KLAC's performance was shaped by overwhelmingly positive fundamentals punctuated by a sharp late-period correction. The stock climbed from approximately $190 in late April to above $300 by late June, fueled by a series of bullish developments. KLA reported strong fiscal Q3 2026 results on April 29, delivering revenue of $3.42 billion and EPS of $9.40 — both exceeding analyst estimates. At its Investor Day in March, management outlined an ambitious 2030 target model of $26 billion in revenue and $84 in EPS.

Analyst sentiment turned increasingly bullish through May and June. Cantor Fitzgerald raised its price target to $325, Morgan Stanley lifted its target to $274, and Stifel increased its target to $270, all citing accelerating wafer fab equipment spending, AI-driven process control demand, and KLA's expanding advanced packaging business. Intel's upward revision of 2026 CapEx to $20 billion further boosted the sector. However, extreme valuations and the subsequent insider selling triggered the late-quarter reversal that erased a significant portion of those gains.

KLAC Stock Forecast Drivers: What Investors Should Watch Next

The immediate focus for KLAC investors is the company's fiscal fourth-quarter 2026 earnings report, scheduled for July 28 after market close. Consensus estimates project EPS of $1.00 on revenue of $3.61 billion. However, investors will pay close attention to management's guidance for fiscal 2027, particularly given the CFO's recent commentary at the J.P. Morgan conference describing "unusually strong" 2027 visibility driven by new fab construction across logic, DRAM, and NAND. Key metrics to watch include gross margin trajectory — which faces headwinds from elevated DRAM costs used in KLA's imaging systems — advanced packaging revenue growth, and any updates on U.S. export controls affecting China, which represented 24% of fiscal Q3 revenue. Additionally, broader macroeconomic conditions, tariff developments, and hyperscaler AI spending trends will continue to influence semiconductor equipment demand and investor sentiment toward the sector. I’m watching this closely ahead of the print.

Using Tickeron’s Trending AI Robots for Market Insights

In my research on volatile names like this, I often review Tickeron’s Trending AI Robots page. It highlights top-performing AI-powered trading bots based on realized returns, win rates, and risk-adjusted metrics across different strategies and timeframes, helping me quickly identify bots generating consistent results without manually reviewing the full marketplace.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: KLAC

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


KLAC's RSI Oscillator recovers from oversold territory

The RSI Oscillator for KLAC moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 11 similar instances when the indicator left oversold territory. In of the 11 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where KLAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KLAC advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

KLAC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KLAC as a result. In of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for KLAC turned negative on July 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

KLAC moved below its 50-day moving average on July 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KLAC crossed bearishly below the 50-day moving average on July 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KLAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KLAC entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KLAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: KLAC's P/B Ratio (39.683) is very high in comparison to the industry average of (8.253). P/E Ratio (52.792) is within average values for comparable stocks, (173.765). Projected Growth (PEG Ratio) (1.847) is also within normal values, averaging (1.534). Dividend Yield (0.004) settles around the average of (0.006) among similar stocks. P/S Ratio (18.762) is also within normal values, averaging (35.325).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 64.45B. The market cap for tickers in the group ranges from 555.66K to 663.18B. ASML holds the highest valuation in this group at 663.18B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 8%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 46%. AXTI experienced the highest price growth at 60%, while SMTK experienced the biggest fall at -26%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was -41% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 43
SMR Rating: 74
Profit Risk Rating: 64
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
KLAC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of process control and yield management solutions for the semiconductor and related nanoelectronics industries

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
One Technology Drive
Phone
+1 408 875-3000
Employees
15200
Web
https://www.kla.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.